Connect with us

Hi, what are you looking for?

Economy

What do the UK allergic reaction cases mean for Pfizer’s COVID-19 vaccine

Image via Reuters

Britain’s medicines regulator has advised people with a history of significant allergies not to get the Pfizer-BioNTech COVID-19 vaccine after two people reported adverse reactions on the first day of its rollout in the UK.

Here are some questions and answers about the cases and what they might mean.

WHAT EXACTLY HAPPENED?
UK officials said there have been two reports of anaphylaxis and one report of a possible allergic reaction since rollout began. Anaphylaxis can cause throat swelling, breathing trouble, and difficulty swallowing, according to the American Academy of Allergy, Asthma & Immunology. Anaphylaxis is an overreaction of the body’s immune system, which the UK National Health Service describes as severe and sometimes life-threatening.

WHO SHOULD NOT GET THE VACCINE, ACCORDING TO UK REGULATORS?
British regulators initially responded by saying anyone with a history of a significant allergic reaction to a vaccine, medicine or food should not take the shot. An adviser to the group later said it was “tweaking” advice in part to say a food allergy was not a risk.

Late on Wednesday, the UK regulator said anyone with a history of anaphylaxis to a vaccine, medicine or food should not get the vaccine.

Pfizer had excluded people with a history of significant adverse reaction to vaccines or its vaccine’s ingredients from late-stage trials.

HOW DOES THIS AFFECT PROSPECTS FOR U.S. AUTHORIZATION?
US regulators are expected to consider emergency authorization of the Pfizer vaccine soon after a Thursday meeting of advisers.

Moncef Slaoui, who is spearheading the US government’s vaccine development efforts, said on Wednesday he expected the British allergic reactions would be considered in the US authorization process and that people with known severe allergic reactions probably should not take the vaccine until more was understood.

WHAT DO DOCTORS SAY?
Some praised UK regulators’ caution, while others said broad restrictions were not warranted by available evidence.

“For the general population, this does not mean that they would need to be anxious about receiving the vaccination,” said Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine.

What would be wise, he said, would be “for anyone who has known severe allergic reaction such that they need to carry an EpiPen to delay having a vaccination until the reason for the allergic reaction has been clarified.”

Mayo Clinic virologist Gregory Poland, who has advised US regulators, described Britain’s early reaction as “overdoing it,” pointing to the initial response about food allergies, which he said “have nothing to do with this.”

“I would have said, ‘If you’ve had anaphylactic-level reactions to vaccines, we want to know about that so we take extra care,’” he said. “That doesn’t mean I wouldn’t immunize you. But I would do it in a more controlled setting.”

Peter Openshaw, a professor of experimental medicine at Imperial College London, praised the way the reactions had been handled. “The fact that we know so soon about these two allergic reactions and that the regulator has acted on this to issue precautionary advice shows that the monitoring system is working well,” he said.

Mitchell Grayson, director of the division of allergy and immunology at Nationwide Children’s Hospital in Ohio, voiced concern over how the issue might reduce interest in vaccinations. “I’m worried the whole event will cause millions of people to choose not to get vaccinated because of what they heard,” he said.

HOW COMMON ARE SEVERE OR SIGNIFICANT ALLERGIES?
“In the UK in 2012 there were around seven hospital admissions per 100,000 people for severe allergies. This included different triggers such as foods, drugs and insect stings,” said Louisa James, an expert in immunology at Queen Mary University of London. Fatalities remain very rare and have not increased even as hospital admissions have risen in many countries. — Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Economy

STOCKS climbed on Tuesday, snapping a three-day losing streak, as investors remained bullish on the Philippines’ prospects, even with inflation hitting a 14-year high...

Economy

THE PESO strengthened versus the dollar on Tuesday despite profit taking after the release of November inflation data that cemented expectations of another rate...

Economy

THE PHILIPPINES has detected one more infection involving the highly contagious Omicron subvariant BQ.1, bringing the total to 17, the Health department said on...

Economy

THE GOVERNMENT of President Ferdinand R. Marcos, Jr. should do more to protect the families of victims of extralegal killings and prosecute officials for...

Economy

AT LEAST P3 billion in public funds was illegally transferred to the Metro Manila Development Authority (MMDA) to finance its free wifi project without...

Economy

AN OPPOSITION senator on Tuesday said the proposal to establish a sovereign wealth fund (SWF) is counterproductive, noting that it goes against the nation’s...

You May Also Like

Investing

The minute that any question pops into your head, you can simply ask Google. No longer do we have to pour over books and...

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Investing

Browsing history makes referring to sites and pages you’ve visited in the past seamless. It’ll help you recall what page you checked out on...

Investing

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.